SOLACI Session

An interventional cardiologist`s perspective on endovascular therapy for AAA

solaci
solaci
446
0

sesion_solaci_acc2013_guering_eid_lidt

Guering Eid-Lidt
2013-03-09

Previous article
CREST, ACT 1 and Other Trials
Next article
Artic Study: Bedside Platelet Function Monitoring to Reduce Events after DES Implantation .
solaci
solaci

More articles by this author

CREST, ACT 1 and Other Trials

solaci - 0
William A. Gray2013-03-09

Endovascular theraphy for acute and critical limb ischemia

solaci - 0
Felix Damas De Los Santos2013-03-10

The Role of the Interventional Cardiologist in the Treatment of Venous Disease

solaci - 0
Oscar Mendiz 2013-03-09

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Session

CREST, ACT 1 and Other Trials

William A. Gray2013-03-09
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

Dr. Andrés Rodríguez - 0
According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

Dr. Andrés Rodríguez - 0
The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Dr. Juan Manuel Pérez - 0
Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...